Proposed Amendments to Regulations 682 and 683 made under the Laboratory and Specimen Collection Centre Licensing Act.
O. Reg. 682 (Laboratories)
O. Reg 683 (Specimen Collection Centres)
Regulation - LGIC
Bill or Act:
Laboratory and Specimen Collection Centre Licensing Act
Summary of Proposal:
As part of the Ontario 2019 budget, the government announced that it will enable regulated health professionals to use their education and training more effectively by expanding the scope of practice for certain regulated health professionals, including NPs, and pharmacists. This commitment was further iterated in the 2019 Ontario Economic Outlook and Fiscal Review.
In response to these commitments, the ministry is proposing to amend Regulation 682 (Laboratories) made under the Laboratory and Specimen Collection Centre Licensing Act (LSCCLA) to authorize NPs to independently perform a broad range of point-of-care tests to assist with diagnosis and the formulation of treatment plans for their patients. Specifically, the proposed amendment to Regulation 682 includes:
• Exempting members of the College of Nurses of Ontario who are registered as Registered Nurses in the Extended Class from certain requirements of the LSCCLA (sections 5 to 16 of the Act) and from provisions of Regulation 682 (Laboratories) for the purposes of performing laboratory tests for the exclusive purpose of diagnosing or treating their patients.
Additionally, the ministry is proposing to amend Regulation 682 (Laboratories) made under the LSCCLA to authorize members of the Ontario College of Pharmacists to perform certain point-of-care tests for medication management of certain chronic diseases. These include:
o Blood glucose
o Hemoglobin A1C
o Prothrombin time and International Normalized Ratio (INR).
The ministry is also proposing to amend Regulation 683 (Specimen Collection Centres) made under the LSCCLA to exempt pharmacists and Registered Nurses in the Extended Class from certain requirements of the LSCCLA and the Regulation for the purposes of collecting specimens from their patient for the purposes of performing point of care tests.
These proposals are not final. The ministry may refine these proposals based on feedback received through this consultation prior to seeking the approval of the Lieutenant Governor in Council.
Analysis of Regulatory Impact:
The proposed amendments will not result in compliance requirements and costs for NPs and pharmacists.
June 24, 2020
Comments Due Date:
August 8, 2020